ENTITY
Sanofi ADR

Sanofi ADR (SNY US)

94
Analysis
Health Care • United States
Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
more
bullish•MSCI ACWI Index
•27 Jul 2018 02:23

Global Strategy: Health Care Outperforming - Overweight; India Breaking Out -Add Exposure

Today's report puts a spotlight on the Health Care Sector, which is assuming a global leadership role vs. other Sectors. We also focus on...

Logo
680 Views
Share
bearish•Sanofi
•30 Jan 2018 12:21

Insider Trading Alleged as Sanofi Continues Its Shopping Spree

The Securities and Exchange Commission (SEC) believes that insider trading occurred around Sanofi (SAN FP) 's $11.6 billion deal for Bioverativ Inc...

Logo
300 Views
Share
bullish•Sanofi
•23 Jan 2018 00:41

Sanofi: Stop the Bleeding with Bioverativ

Today, Sanofi (SAN FP) announced that it is acquiring Bioverativ Inc (BIVV US) for $11.6 billion (a 64% premium).  Management hosted a conference...

Logo
376 Views
Share
•08 Nov 2017 20:24

Genomics as an Investment Theme

Genomics as an investment theme Costs of sequencing a human genome have fallen to less than $1,000 China leads the world in gene sequencing The...

Logo
392 Views
Share
bearish•Celltrion Healthcare
•08 Sep 2017 10:35

Surveying The Biosimilar Battlefield

The biosimilar market has been of particular interest to us in light of the high expectations set for Samsung Biologics Co., Ltd (207940 KS)  and...

Share
x